|
|
|
|
|
|
Pharmatera Journal is committed to maintaining transparency, objectivity, and integrity throughout the scientific publication process. The journal follows the ethical principles and recommendations established by the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) regarding the disclosure and management of conflicts of interest.
A conflict of interest occurs when an author's, editor's, or reviewer's professional judgment concerning a primary interest, such as scientific validity and research integrity, may be influenced by secondary interests, including financial relationships, personal relationships, institutional affiliations, or academic competition.
All parties involved in the publication process are required to disclose any actual, potential, or perceived conflicts of interest that could influence the research, manuscript evaluation, or publication decisions.
Authors must disclose all financial and non-financial relationships that could potentially influence the design, conduct, analysis, interpretation, or reporting of their research.
Potential conflicts of interest may include:
Financial Interests: Research grants, sponsorships, employment, consultancy fees, honoraria, stock ownership, patents, royalties, or other financial relationships with organizations that may benefit from the research findings.
Personal Relationships: Family relationships, close personal connections, or other associations that could influence the objectivity of the research.
Professional and Academic Interests: Institutional affiliations, academic competition, professional collaborations, or other relationships that could affect research independence.
Institutional Interests: Relationships with institutions, organizations, or companies that may have a direct interest in the research outcomes.
Authors must provide a clear Conflict of Interest Statement when submitting their manuscripts.
If no conflicts of interest exist, authors should include the following statement:
"The authors declare that they have no conflicts of interest regarding the publication of this article."
If conflicts of interest exist, authors must describe the nature of the relationships and explain their potential relevance to the research.
Editors are responsible for ensuring that editorial decisions are made independently and objectively based on the scientific merit, originality, and relevance of submitted manuscripts.
Editors must disclose any financial, personal, professional, or institutional relationships that could compromise their impartiality.
Editors must not handle manuscripts when they have conflicts of interest involving the authors, research institutions, funding organizations, or subject matter.
In such cases, editorial responsibility must be assigned to another qualified editor who has no relevant conflicts of interest.
Peer reviewers must disclose any potential conflicts of interest before accepting a manuscript review assignment.
Reviewers should decline invitations to review manuscripts when financial relationships, personal connections, academic competition, recent collaborations, or institutional affiliations could compromise their objectivity.
Reviewers must provide fair, unbiased, and constructive evaluations based solely on the scientific quality and relevance of the manuscript.
Confidential information obtained during the peer-review process must not be used for personal, professional, or financial advantage.
Authors must disclose all sources of financial support received for the research, including institutional funding, research grants, commercial sponsorships, and other financial contributions.
Authors should also describe the role of funding organizations in the study design, data collection, analysis, interpretation, manuscript preparation, and publication decisions, where applicable.
If the research received no external financial support, authors should include the following statement:
"This research received no external funding."
Pharmatera Journal evaluates disclosed conflicts of interest to determine whether additional measures are necessary to maintain the integrity and independence of the editorial process.
Depending on the circumstances, the Editorial Board may take appropriate actions, including requesting additional disclosures, assigning independent reviewers, replacing editors or reviewers with conflicts of interest, or publishing relevant conflict of interest statements.
The existence of a conflict of interest does not automatically disqualify a manuscript from publication. However, failure to disclose relevant conflicts of interest may result in editorial action.
If an undisclosed conflict of interest is identified during manuscript evaluation or after publication, Pharmatera Journal will investigate the matter in accordance with COPE guidelines.
The authors or other parties involved will be given an opportunity to provide clarification and relevant supporting information.
Depending on the severity and impact of the undisclosed conflict, editorial actions may include requesting a corrected disclosure statement, issuing a correction notice, rejecting the manuscript, or considering further action when the integrity of the published work is compromised.
By submitting a manuscript to Pharmatera Journal, all authors confirm that they have disclosed any relationships or circumstances that could reasonably be perceived as influencing their research.
The corresponding author is responsible for ensuring that conflict of interest declarations from all co-authors are complete and accurate.
Pharmatera Journal is dedicated to promoting ethical scholarly publishing by ensuring transparency, fairness, accountability, and independence in all editorial and publication activities.
References:
Committee on Publication Ethics (COPE): https://publicationethics.org/
International Committee of Medical Journal Editors (ICMJE): https://www.icmje.org/
|
|
|
|
|
|
Copyright of PHARMATERA JOURNAL (e-ISSN: XXXX-XXXX)

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Publisher:
CV. Q2 LANTERA ILMIAH INSTITUTE
Email: adminojs@q2lii.id